title: The learning curve for neuroendovascular procedures: how important is it?
authors.forename: Seemant
authors.initials: S
authors.lastname: Chaturvedi
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Dumont
mesh_terms: D000046:Academic Medical Centers / Q000706:statistics & numerical data; D017130:Angioplasty / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D020520:Brain Infarction / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000150:complications / Q000628:therapy*; D002983:Clinical Competence / Q000592:standards / Q000706:statistics & numerical data*; D004351:Drug Resistance / Q000502:physiology; D023381:Endpoint Determination / Q000379:methods; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011183:Postoperative Complications / Q000401:mortality* / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods / Q000592:standards; D012042:Registries / Q000706:statistics & numerical data; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects / Q000706:statistics & numerical data; D020521:Stroke / Q000209:etiology / Q000401:mortality* / Q000517:prevention & control; D013663:Teaching / Q000706:statistics & numerical data; D014656:Vascular Surgical Procedures / Q000009:adverse effects* / Q000295:instrumentation / Q000401:mortality*
chemical_list: D010975:Platelet Aggregation Inhibitors